• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

换血疗法用于治疗中间型地中海贫血的腿部溃疡。

Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.

作者信息

Aessopos Athanasios, Kati Maria, Tsironi Maria, Polonifi Ekaterini, Farmakis Dimitrios

机构信息

Cardiac Outpatient Clinic for Hemoglobinopathies, First Department of Internal Medicine, University of Athens Medical School, Laiko Hospital, Athens, Greece.

出版信息

Haematologica. 2006 May;91(5 Suppl):ECR11.

PMID:16709519
Abstract

Thalassemia intermedia is a heterogeneous, transfusion-independent form of b-thalassemia, with a clinical course dominated by multi-organ effects of chronic tissue hypoxia, in which hemoglobin F percentage seems to play an important role. We describe the case of a transfusion-independent thalassemia intermedia patient (total hemoglobin 10.7 g/dl) with high hemoglobin F percentage (70%), who presented with persistent leg ulcerations. The patient was successfully treated with one-year exchange blood transfusions, which reduced hemoglobin F percentage to 35%.

摘要

中间型地中海贫血是一种异质性、无需输血的β地中海贫血形式,其临床病程以慢性组织缺氧的多器官影响为主,其中血红蛋白F百分比似乎起重要作用。我们描述了一例无需输血的中间型地中海贫血患者(总血红蛋白10.7 g/dl),其血红蛋白F百分比高(70%),出现持续性腿部溃疡。该患者通过为期一年的换血输血治疗成功治愈,血红蛋白F百分比降至35%。

相似文献

1
Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.换血疗法用于治疗中间型地中海贫血的腿部溃疡。
Haematologica. 2006 May;91(5 Suppl):ECR11.
2
Thalassemia intermedia: revisited.中间型地中海贫血:再探讨
Blood Cells Mol Dis. 2006 Jul-Aug;37(1):12-20. doi: 10.1016/j.bcmd.2006.04.005. Epub 2006 Jun 5.
3
Beta-thalassemia and pulmonary function.β地中海贫血与肺功能
Haematologica. 1999 Sep;84(9):804-8.
4
[Arrhythmia in thalassemia major: evaluation of iron chelating therapy by dynamic ECG].[重型地中海贫血中的心律失常:动态心电图对铁螯合疗法的评估]
Minerva Cardioangiol. 1993 Jul-Aug;41(7-8):297-301.
5
Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.用重组人促红细胞生成素治疗β地中海贫血患者:对输血需求和可溶性黏附分子的影响。
Acta Haematol. 2004;111(4):189-95. doi: 10.1159/000077551.
6
Response to hydroxyurea therapy in beta-thalassemia.β地中海贫血对羟基脲治疗的反应
Am J Hematol. 2008 May;83(5):366-70. doi: 10.1002/ajh.21120.
7
Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.美国接受去铁胺治疗的地中海贫血和镰状细胞病患者的治疗结果、医疗服务利用情况及费用
Am J Hematol. 2008 Apr;83(4):263-70. doi: 10.1002/ajh.21049.
8
Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.重型β地中海贫血输血周期中的非转铁蛋白结合铁
Ann N Y Acad Sci. 2005;1054:429-32. doi: 10.1196/annals.1345.074.
9
[Therapeuetic management of patients with thalassemia major].[重型地中海贫血患者的治疗管理]
Bull Soc Pathol Exot. 2001 May;94(2):95-7.
10
β-Thalassemia intermedia: a comprehensive overview and novel approaches.中间型β地中海贫血:全面综述与新方法
Int J Hematol. 2018 Jul;108(1):5-21. doi: 10.1007/s12185-018-2411-9. Epub 2018 Jan 29.

引用本文的文献

1
Novel Red Blood Cell Exchange Parameters for Treatment of Transfusion-Dependent Thalassemia Based on Experience of Five Patients.基于五例患者经验的新型红细胞置换参数用于治疗依赖输血的地中海贫血
J Hematol. 2025 Jul 8;14(4):210-213. doi: 10.14740/jh2086. eCollection 2025 Aug.
2
Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia.下肢溃疡:血红蛋白 E 贝塔地中海贫血患者的报告,并对严重贝塔地中海贫血文献的回顾。
Acta Haematol. 2022;145(3):334-343. doi: 10.1159/000520731. Epub 2021 Nov 9.
3
Red Blood Cell Exchange in a Patient With Extramedullary Hematopoiesis and Cor Pulmonale Secondary to Beta Thalassemia.
β地中海贫血继发髓外造血和肺心病患者的红细胞置换术
Cureus. 2021 Mar 1;13(3):e13638. doi: 10.7759/cureus.13638.
4
The variable manifestations of disease in pyruvate kinase deficiency and their management.丙酮酸激酶缺乏症的疾病表现多变及其处理方法。
Haematologica. 2020 Sep 1;105(9):2229-2239. doi: 10.3324/haematol.2019.240846.
5
Thalassaemia intermedia: the role of erythroexchange in the treatment of an indolent wound.中间型地中海贫血:红细胞置换术在治疗慢性伤口中的作用
Blood Transfus. 2014 Jan;12(1):124-6. doi: 10.2450/2013.0181-13. Epub 2013 Nov 14.
6
Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.地中海贫血和中间型地中海贫血的心脏功能和铁螯合作用:对潜在病理生理学和螯合管理方法的综述。
Mediterr J Hematol Infect Dis. 2009 Jul 18;1(1):e2009002. doi: 10.4084/MJHID.2009.002.